Antidote competitors
Antidote's competitors include Mast Therapeutics, Sucampo Pharmaceuticals, BTG and Zogenix
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Antidote Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ||
Founding Date | Founding Date 2009 | Founding Date 1995 | Founding Date 1996 | Founding Date 1948 | Founding Date 2006 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations London, GB HQ New York, US Carmel, US | Locations San Diego, US HQ | Locations Rockville, US HQ Kita Ward, JP Chiyoda, JP Chuo Ward, JP Sanda Shi, JP Zug, CH Milton, GB | Locations London, GB HQ Rosedale, AU Ottawa, CA Düsseldorf, DE Hong Kong , HK Ataşehir, TR Surrey, GB see more | Locations Emeryville, US HQ Maidenhead, GB San Diego, US |
Employees | Employees 696% increase | Employees 14133% increase | Employees 139 | Employees 1,355 | Employees 67 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 384 m | Valuation ($) 1.2 b | Valuation ($) 3.9 b | Valuation ($) 2.1 b |
Facebook likes | Facebook likes 104 k | Facebook likes 310 | Facebook likes N/A | Facebook likes N/A | Facebook likes N/A |
Twitter followers | Twitter followers 1 | Twitter followers 873 | Twitter followers 242 | Twitter followers 786 | Twitter followers 475 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) £2.4m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) £570.5m (FY, 2017) | Revenue (est.) $9.8m (FY, 2017) |
Cost of goods | Cost of goods £1.1m (FY, 2016) | Cost of goods N/A | Cost of goods $76m (FY, 2016) | Cost of goods £179.9m (FY, 2017) | Cost of goods $10.7m (FY, 2017) |
Gross profit | Gross profit £1.3m (FY, 2016) | Gross profit N/A | Gross profit $154.1m (FY, 2016) | Gross profit £390.6m (FY, 2017) | Gross profit ($908k) (FY, 2017) |
Net income | Net income (£3.3m) (FY, 2016) | Net income ($29.8m) (FY, 2017) | Net income $18.5m (FY, 2016) | Net income £33.6m (FY, 2017) | Net income ($126.8m) (FY, 2017) |
For sources of this data, please see the company profileDownload Excel
View company profiles
Sucampo Pharmaceuticals
HQ
Rockville, US
Employees
139
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View companyZogenix
HQ
Emeryville, US
Employees
67
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company